This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsRe:NewCell（6QP）株式概要Re:NewCell AB (publ) operates as a textile recycling company in Sweden. 詳細6QP ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長2/6過去の実績0/6財務の健全性1/6配当金0/6報酬収益は年間82.95%増加すると予測されています リスク分析キャッシュランウェイが1年未満である German市場と比較して、過去 3 か月間の株価の変動が非常に大きい現在は利益が出ておらず、今後3年間で利益が出る見込みはない 過去1年間で株主の希薄化が進んだ +1 さらなるリスクすべてのリスクチェックを見る6QP Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.4593.9% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-912m4b2016201920222025202620282031Revenue SEK 4.2bEarnings SEK 394.6mAdvancedSet Fair ValueView all narrativesRe:NewCell AB (publ) 競合他社IBU-tec advanced materialsSymbol: XTRA:IBUMarket cap: €77.2mSIMONASymbol: DB:SIM0Market cap: €300.0mOTI GreentechSymbol: DUSE:NSAKMarket cap: €311.5kPPK GroupSymbol: ASX:PPKMarket cap: AU$28.1m価格と性能株価の高値、安値、推移の概要Re:NewCell過去の株価現在の株価SEK 0.4552週高値SEK 8.2452週安値SEK 0.40ベータ1.61ヶ月の変化-49.04%3ヶ月変化-30.56%1年変化-94.32%3年間の変化-98.13%5年間の変化n/aIPOからの変化-96.13%最新ニュースお知らせ • Jun 05Altor Equity Partners AB acquired Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ).Altor Equity Partners AB acquired Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ) on June 4, 2024.Altor Equity Partners AB completed the acquisition of Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ) on June 4, 2024.お知らせ • Jan 10Re:NewCell AB Plans for Restructuring to Strengthen Organization Within Continuous Focus on SalesRe:NewCell AB announced that they are planning to start negotiations with the relevant trade unions regarding restructuring of the organization to improve efficiency while maintaining focus on sales. As part of the restructuring, the local authorities (Arbetsförmedlingen) will also be notified today. The planned restructuring will lead to a decrease in workforce of approximately 25%, just over 30 persons, and will also result in annual savings - reduction of personnel cost and other operating costs - of approximately 35 SEKm in total per annum when finalized.お知らせ • Dec 23+ 1 more updateRe:NewCell AB (publ) to Report Q3, 2024 Results on Nov 06, 2024Re:NewCell AB (publ) announced that they will report Q3, 2024 results on Nov 06, 2024New Risk • Dec 23New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: kr401m Forecast net loss in 2 years: kr27m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr578m free cash flow). Share price has been highly volatile over the past 3 months (31% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (kr27m net loss in 2 years). Shareholders have been diluted in the past year (11% increase in shares outstanding). Market cap is less than US$100m (€32.0m market cap, or US$35.3m).お知らせ • Dec 13Peter Schulz Joins as Interim CFO at Re:NewCell AB (publ) Effective 1 January 2024Re:NewCell AB (publ) announced Peter Schulz will join the company in the role of interim Chief Financial Officer (CFO) from 1 January 2024. He comes from a role as CFO at Pacific Basin Shipping (publ.) in Hong Kong, a position he has held for the past six years. Peter Schulz has extensive experience as CFO from both listed and private companies for the last 10 years. Prior to that Peter Schulz spent more than 15 years, and held senior positions, in investment banking in Stockholm, London and Hong Kong, among others with Royal Bank of Canada and ABN Amro. With his extensive and broad experience, he will contribute well to the management team and the company.Breakeven Date Change • Nov 25Forecast to breakeven in 2025The 3 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 30% per year to 2024. The company is expected to make a profit of kr12.8m in 2025. Average annual earnings growth of 82% is required to achieve expected profit on schedule.最新情報をもっと見るRecent updatesお知らせ • Jun 05Altor Equity Partners AB acquired Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ).Altor Equity Partners AB acquired Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ) on June 4, 2024.Altor Equity Partners AB completed the acquisition of Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ) on June 4, 2024.お知らせ • Jan 10Re:NewCell AB Plans for Restructuring to Strengthen Organization Within Continuous Focus on SalesRe:NewCell AB announced that they are planning to start negotiations with the relevant trade unions regarding restructuring of the organization to improve efficiency while maintaining focus on sales. As part of the restructuring, the local authorities (Arbetsförmedlingen) will also be notified today. The planned restructuring will lead to a decrease in workforce of approximately 25%, just over 30 persons, and will also result in annual savings - reduction of personnel cost and other operating costs - of approximately 35 SEKm in total per annum when finalized.お知らせ • Dec 23+ 1 more updateRe:NewCell AB (publ) to Report Q3, 2024 Results on Nov 06, 2024Re:NewCell AB (publ) announced that they will report Q3, 2024 results on Nov 06, 2024New Risk • Dec 23New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: kr401m Forecast net loss in 2 years: kr27m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr578m free cash flow). Share price has been highly volatile over the past 3 months (31% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (kr27m net loss in 2 years). Shareholders have been diluted in the past year (11% increase in shares outstanding). Market cap is less than US$100m (€32.0m market cap, or US$35.3m).お知らせ • Dec 13Peter Schulz Joins as Interim CFO at Re:NewCell AB (publ) Effective 1 January 2024Re:NewCell AB (publ) announced Peter Schulz will join the company in the role of interim Chief Financial Officer (CFO) from 1 January 2024. He comes from a role as CFO at Pacific Basin Shipping (publ.) in Hong Kong, a position he has held for the past six years. Peter Schulz has extensive experience as CFO from both listed and private companies for the last 10 years. Prior to that Peter Schulz spent more than 15 years, and held senior positions, in investment banking in Stockholm, London and Hong Kong, among others with Royal Bank of Canada and ABN Amro. With his extensive and broad experience, he will contribute well to the management team and the company.Breakeven Date Change • Nov 25Forecast to breakeven in 2025The 3 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 30% per year to 2024. The company is expected to make a profit of kr12.8m in 2025. Average annual earnings growth of 82% is required to achieve expected profit on schedule.Breakeven Date Change • Nov 24Forecast to breakeven in 2025The 3 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 30% per year to 2024. The company is expected to make a profit of kr12.8m in 2025. Average annual earnings growth of 82% is required to achieve expected profit on schedule.Reported Earnings • Nov 08Third quarter 2023 earnings released: kr2.31 loss per share (vs kr2.99 loss in 3Q 2022)Third quarter 2023 results: kr2.31 loss per share (improved from kr2.99 loss in 3Q 2022). Revenue: kr86.1m (up kr83.1m from 3Q 2022). Net loss: kr94.5m (loss narrowed 6.9% from 3Q 2022). Revenue is forecast to grow 82% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Germany.New Risk • Nov 08New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 1.4% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr786m free cash flow). Share price has been highly volatile over the past 3 months (29% average weekly change). Earnings are forecast to decline by an average of 1.4% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (kr107m net loss in 2 years). Shareholders have been diluted in the past year (13% increase in shares outstanding). Market cap is less than US$100m (€35.4m market cap, or US$37.8m).お知らせ • Nov 07Re:NewCell AB (publ) to Report Fiscal Year 2023 Final Results on Apr 26, 2024Re:NewCell AB (publ) announced that they will report fiscal year 2023 final results on Apr 26, 2024お知らせ • Oct 18Re:NewCell AB (publ) Announces CEO ChangesRe:NewCell AB (publ) announced that the Board has appointed Magnus Håkansson as the new acting CEO. Magnus has solid experience from leading roles in the retail and fashion sector and from leadership in a listed environment. He will start on October 16, 2023 and replaces Patrik Lundström, who has been the company's CEO since 2019. Magnus Håkansson was born in 1963, has a degree in economics from the Stockholm School of Economics and an MBA from MIT Sloan School of Management. He started his career as a management consultant at McKinsey and has since held several leading roles in global growth companies in the retail sector, as well as the pulp industry, including many years with experience from a listed environment. He most recently came from a role as CEO of MediaMarkt Sweden.Breakeven Date Change • Oct 16Forecast breakeven date pushed back to 2025The 3 analysts covering Re:NewCell previously expected the company to break even in 2024. New consensus forecast suggests losses will reduce by 52% per year to 2024. The company is expected to make a profit of kr378.3m in 2025. Average annual earnings growth of 104% is required to achieve expected profit on schedule.New Risk • Oct 13New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €49.0m (US$51.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr786m free cash flow). Share price has been highly volatile over the past 3 months (24% average weekly change). Minor Risks Shareholders have been diluted in the past year (22% increase in shares outstanding). Significant insider selling over the past 3 months (€1.4m sold). Market cap is less than US$100m (€49.0m market cap, or US$51.4m).お知らせ • Oct 13Re:Newcell AB (Publ) Provides Earnings Guidance for the Third Quarter of 2023Re:NewCell AB (publ) provided earnings guidance for the third quarter of 2023. For the quarter, the company expected to report Net loss of approximately SEK 105 million.Recent Insider Transactions • Oct 10CEO & MD recently sold €299k worth of stockOn the 6th of October, Patrik Lundstrom sold around 109k shares on-market at roughly €2.74 per share. This transaction amounted to 12% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth €1.4m. Patrik has been a net seller over the last 12 months, reducing personal holdings by €1.7m.Reported Earnings • Aug 30Second quarter 2023 earnings released: kr2.82 loss per share (vs kr2.09 loss in 2Q 2022)Second quarter 2023 results: kr2.82 loss per share (further deteriorated from kr2.09 loss in 2Q 2022). Revenue: kr86.0m (up kr83.5m from 2Q 2022). Net loss: kr105.4m (loss widened 54% from 2Q 2022). Revenue is forecast to grow 78% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany.お知らせ • Aug 30+ 2 more updatesRe:NewCell AB (publ) to Report Q4, 2023 Results on Feb 13, 2024Re:NewCell AB (publ) announced that they will report Q4, 2023 results on Feb 13, 2024Breakeven Date Change • Aug 24Forecast breakeven date pushed back to 2025The 2 analysts covering Re:NewCell previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of kr233.9m in 2025. Average annual earnings growth of 73% is required to achieve expected profit on schedule.Recent Insider Transactions • Aug 01CEO & MD recently sold €1.4m worth of stockOn the 27th of July, Patrik Lundstrom sold around 224k shares on-market at roughly €6.20 per share. This transaction amounted to 33% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Patrik's only on-market trade for the last 12 months.お知らせ • Jul 17Re:NewCell AB (publ) Announces Toby Lawton to Leave His Position as CFORe:NewCell AB (publ) Toby Lawton, CFO at Renewcell AB (publ), has announced that he will leave his position for a similar position in another company. Toby will continue to work as CFO until a successor has been appointed or at the latest until the end of the year.お知らせ • Jul 01Re:Newcell AB (Publ) Provides Production from Renewcell 1 Guidance in June 2023Re:NewCell AB (publ) provided production from Renewcell 1 guidance in June 2023. Production from Renewcell 1 is expected to reach 2,200-2,400 metric tons in June 2023, of which 2,100-2,300 metric tons are expected to be of prime quality and 2,200-2,400 metric tons are expected to be delivered to customers. The production in the month has been impacted by maintenance stops to upgrade and install new equipment in the shredding area.Reported Earnings • Apr 30Full year 2022 earnings released: kr8.99 loss per share (vs kr4.33 loss in FY 2021)Full year 2022 results: kr8.99 loss per share (further deteriorated from kr4.33 loss in FY 2021). Net loss: kr299.9m (loss widened 125% from FY 2021). Revenue is forecast to grow 71% p.a. on average during the next 3 years, compared to a 1.7% growth forecast for the Chemicals industry in Germany.お知らせ • Feb 16+ 1 more updateRe:NewCell AB (publ) to Report Q3, 2023 Results on Nov 07, 2023Re:NewCell AB (publ) announced that they will report Q3, 2023 results on Nov 07, 2023Reported Earnings • Feb 16Full year 2022 earnings released: kr8.99 loss per share (vs kr4.33 loss in FY 2021)Full year 2022 results: kr8.99 loss per share (further deteriorated from kr4.33 loss in FY 2021). Net loss: kr299.9m (loss widened 125% from FY 2021). Revenue is forecast to grow 69% p.a. on average during the next 3 years, compared to a 1.5% growth forecast for the Chemicals industry in Germany.Breakeven Date Change • Feb 08Forecast to breakeven in 2024The 2 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of kr51.6m in 2024. Average annual earnings growth of 66% is required to achieve expected profit on schedule.Breakeven Date Change • Nov 29Forecast breakeven date pushed back to 2024The 2 analysts covering Re:NewCell previously expected the company to break even in 2023. New consensus forecast suggests losses will reduce by 22% per year to 2023. The company is expected to make a profit of kr118.9m in 2024. Average annual earnings growth of 72% is required to achieve expected profit on schedule.Board Change • Nov 16High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Independent Director Om Bhatia is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Nov 04Re:Newcell AB (Publ) Appoints Tricia Carey as Chief Commercial OfficerRe:NewCell AB (publ) strengthens its commercial team with the addition of Tricia Carey as Chief Commercial Officer. Mrs. Carey is a seasoned fashion industry executive with more than 25 years of experience promoting more circular and more sustainable materials within fashion. She has also been a catalyst for the industry-wide conversation around the shift to more climate-friendly and resource-efficient materials as a board member at Textile Exchange and Accelerating Circularity. Prior to joining Renewcell, Mrs. Carey held the position of Director of Global Business Development at the leading Austrian fiber producer Lenzing. About Tricia Carey: Throughout her career, Tricia believes in ‘progress over perfection'. As an advocate for innovation and circularity in the textile and apparel industry, she recently joined Renewcell to accelerate the commercial development of Circulose®, making fashion circular. With a vast global network, as well as experience in brand building, and business development, she will be an important partner to close the loop and optimize the benefits of Circulose®. For more than twenty years, Tricia held various commercial management positions at Lenzing Fibers to establish the TENCEL™ brand, build mill partners and set retailer specifications. Her roles comprised marketing, Americas business development, and global denim segment expansion including the creation of the Carved in Blue platform and numerous collaborative collections with mills and brands. Tricia holds a bachelor's degree in Fashion Merchandising from The Fashion Institute of Technology, as well as certificates in Digital Marketing and Strategy from Cornell University and MIT.Reported Earnings • Oct 29Third quarter 2022 earnings released: kr2.99 loss per share (vs kr0.80 loss in 3Q 2021)Third quarter 2022 results: kr2.99 loss per share (further deteriorated from kr0.80 loss in 3Q 2021). Net loss: kr101.5m (loss widened 314% from 3Q 2021). Revenue is forecast to grow 82% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat.Breakeven Date Change • Oct 29Forecast breakeven date pushed back to 2024The 2 analysts covering Re:NewCell previously expected the company to break even in 2023. New consensus forecast suggests losses will reduce by 65% per year to 2023. The company is expected to make a profit of kr122.1m in 2024. Average annual earnings growth of 75% is required to achieve expected profit on schedule.お知らせ • Oct 28+ 1 more updateRe:NewCell AB (publ) to Report Q2, 2023 Results on Aug 18, 2023Re:NewCell AB (publ) announced that they will report Q2, 2023 results on Aug 18, 2023Reported Earnings • Aug 27Second quarter 2022 earnings released: kr2.09 loss per share (vs kr0.76 loss in 2Q 2021)Second quarter 2022 results: kr2.09 loss per share (down from kr0.76 loss in 2Q 2021). Net loss: kr68.4m (loss widened 192% from 2Q 2021). Over the next year, revenue is forecast to grow 3,859%, compared to a 2.4% growth forecast for the Chemicals industry in Germany.お知らせ • Jul 05Re:NewCell AB Appoints Toby Lawton as New Chief Financial Officer, Effective October 1, 2022Re:NewCell AB (publ) announced that Toby Lawton will join the company in the role of Chief Financial Officer. He comes from a role as CFO at SCA, a position he has held for the past five years. Toby brings extensive experience from leadership positions over a two decade career with the publicly listed companies Svenska Cellulosa AB (SCA) in Sweden and Vinda International in Hong Kong. His expertise in financing large scale international projects and operational management within pulp and paper and consumer products industries will strengthen Renewcell’s scaling efforts. Toby Lawton will assume his new position at Renewcell on October 1, 2022. Hugo Petit, Renewcell’s current CFO, will remain as CFO until October 1, 2022.Board Change • Jun 02High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Independent Director Om Bhatia is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • May 18Re:Newcell AB (Publ) Announces Executive ChangesRe:NewCell AB (publ) announced that at its Annual General Meeting held on 17 May 2022 elected Michael Berg as members of the Board of Directors for the period until the end of the next Annual General Meeting. It was noted that Mia Hemmingson has declined re-election as Chairman of the Board. Michael Berg was elected Chairman of the Board.Reported Earnings • May 05First quarter 2022 earnings released: kr1.75 loss per share (vs kr0.63 loss in 1Q 2021)First quarter 2022 results: kr1.75 loss per share (down from kr0.63 loss in 1Q 2021). Net loss: kr54.0m (loss widened 181% from 1Q 2021). Over the next year, revenue is forecast to grow 4,106%, compared to a 8.5% growth forecast for the industry in Germany.お知らせ • May 05Re:NewCell AB (publ) to Report Q1, 2023 Results on May 03, 2023Re:NewCell AB (publ) announced that they will report Q1, 2023 results on May 03, 2023Board Change • Apr 27High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Om Bhatia is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Breakeven Date Change • Mar 09Forecast breakeven date moved forward to 2023The 2 analysts covering Re:NewCell previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of kr37.9m in 2023. Average annual earnings growth of 59% is required to achieve expected profit on schedule.Breakeven Date Change • Feb 19Forecast breakeven date moved forward to 2023The 2 analysts covering Re:NewCell previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of kr37.9m in 2023. Average annual earnings growth of 59% is required to achieve expected profit on schedule.Reported Earnings • Feb 17Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: kr4.33 loss per share (down from kr3.34 loss in FY 2020). Net loss: kr133.4m (loss widened 94% from FY 2020). Revenue exceeded analyst estimates by 10%. Over the next year, revenue is forecast to grow 1,979%, compared to a 6.5% growth forecast for the industry in Germany.お知らせ • Feb 17Re:NewCell AB (publ) to Report Q4, 2022 Results on Feb 15, 2023Re:NewCell AB (publ) announced that they will report Q4, 2022 results on Feb 15, 2023お知らせ • Feb 16Re:NewCell AB (publ) Provides Production Guidance for the Year 2022Re:NewCell AB (publ) provided production guidance for the year 2022. The company expects production of 60,000 metric tons.お知らせ • Feb 07+ 2 more updatesRe:NewCell AB (publ), Annual General Meeting, May 17, 2022Re:NewCell AB (publ), Annual General Meeting, May 17, 2022.Breakeven Date Change • Jan 28Forecast to breakeven in 2024The 2 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of kr5.77m in 2024. Average annual earnings growth of 59% is required to achieve expected profit on schedule.Breakeven Date Change • Jan 07Forecast to breakeven in 2024The 2 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of kr5.77m in 2024. Average annual earnings growth of 59% is required to achieve expected profit on schedule.Breakeven Date Change • Jan 01Forecast to breakeven in 2024The 2 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of kr5.77m in 2024. Average annual earnings growth of 59% is required to achieve expected profit on schedule.Reported Earnings • Nov 07Third quarter 2021 earnings released: kr0.80 loss per share (vs kr0.81 loss in 3Q 2020)Third quarter 2021 results: Net loss: kr24.5m (loss widened 55% from 3Q 2020).Recent Insider Transactions • Jun 25Plant Manager Ortviken recently bought €11k worth of stockOn the 21st of June, Henrik Dahlbom bought around 700 shares on-market at roughly €15.19 per share. In the last 3 months, there was an even bigger purchase from another insider worth €51k. Insiders have collectively bought €148k more in shares than they have sold in the last 12 months.Recent Insider Transactions • Jun 13Chief Executive Officer recently bought €51k worth of stockOn the 11th of June, Patrik Lundstrom bought around 3k shares on-market at roughly €18.20 per share. This was the largest purchase by an insider in the last 3 months. This was Patrik's only on-market trade for the last 12 months.Executive Departure • May 22Director has left the companyOn the 19th of May, Erik Karlsson's tenure in the role of Director ended. We don't have any record of a personal shareholding under Erik's name. A total of 3 executives have left over the last 12 months.Executive Departure • May 22Director has left the companyOn the 19th of May, Henrik Norlin's tenure in the role of Director ended. We don't have any record of a personal shareholding under Henrik's name. A total of 3 executives have left over the last 12 months.Reported Earnings • May 05First quarter 2021 earnings releasedFirst quarter 2021 results: Net loss: kr19.3m (loss widened 58% from 1Q 2020).お知らせ • Mar 05Renewcell Awarded Afry an Engineering Assignment for Their Recycled Textile Materials Production Expansion at Sca's Ortviken Paper Mill in Sundsvall, SwedenRenewcell has awarded AFRY an engineering assignment for their recycled textile materials production expansion at SCA's Ortviken paper mill in Sundsvall, Sweden. The assignment includes project and construction management services, process, mechanical and piping engineering, electrical, automation and instrumentation engineering, fire and HVAC design, as well as civil design. The project is a continuation of AFRY's previous feasibility studies. The trend in textiles and design requires sustainable fashion. Customers require fashion companies to reduce their environmental impact through new technologies and innovations for the circular economy. One important element is recycling of textile fibers that is a path towards a more sustainable fashion.株主還元6QPDE ChemicalsDE 市場7D0.8%-0.3%3.2%1Y-94.3%5.7%2.5%株主還元を見る業界別リターン: 6QP過去 1 年間で5.7 % の収益を上げたGerman Chemicals業界を下回りました。リターン対市場: 6QPは、過去 1 年間で2.5 % のリターンを上げたGerman市場を下回りました。価格変動Is 6QP's price volatile compared to industry and market?6QP volatility6QP Average Weekly Movement13.2%Chemicals Industry Average Movement6.0%Market Average Movement6.1%10% most volatile stocks in DE Market13.6%10% least volatile stocks in DE Market2.7%安定した株価: 6QPの株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 6QPの 週次ボラティリティ は過去 1 年間で18%から13%に減少しましたが、依然としてGerman株の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト2012123Magnus Håkanssonwww.renewcell.comもっと見るRe:NewCell AB (publ) 基礎のまとめRe:NewCell の収益と売上を時価総額と比較するとどうか。6QP 基礎統計学時価総額€19.54m収益（TTM）-€35.80m売上高(TTM)€18.30m1.1xP/Sレシオ-0.5xPER（株価収益率6QP は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計6QP 損益計算書（TTM）収益SEK 205.18m売上原価SEK 288.15m売上総利益-SEK 82.97mその他の費用SEK 318.38m収益-SEK 401.35m直近の収益報告Sep 30, 2023次回決算日Apr 26, 2024一株当たり利益（EPS）-9.71グロス・マージン-40.44%純利益率-195.60%有利子負債／自己資本比率102.7%6QP の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/02/29 15:48終値2024/02/29 00:00収益2023/09/30年間収益2022/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Re:NewCell AB (publ) 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Daniel OvinNordea MarketsJohan SpetzPareto Securities
お知らせ • Jun 05Altor Equity Partners AB acquired Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ).Altor Equity Partners AB acquired Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ) on June 4, 2024.Altor Equity Partners AB completed the acquisition of Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ) on June 4, 2024.
お知らせ • Jan 10Re:NewCell AB Plans for Restructuring to Strengthen Organization Within Continuous Focus on SalesRe:NewCell AB announced that they are planning to start negotiations with the relevant trade unions regarding restructuring of the organization to improve efficiency while maintaining focus on sales. As part of the restructuring, the local authorities (Arbetsförmedlingen) will also be notified today. The planned restructuring will lead to a decrease in workforce of approximately 25%, just over 30 persons, and will also result in annual savings - reduction of personnel cost and other operating costs - of approximately 35 SEKm in total per annum when finalized.
お知らせ • Dec 23+ 1 more updateRe:NewCell AB (publ) to Report Q3, 2024 Results on Nov 06, 2024Re:NewCell AB (publ) announced that they will report Q3, 2024 results on Nov 06, 2024
New Risk • Dec 23New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: kr401m Forecast net loss in 2 years: kr27m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr578m free cash flow). Share price has been highly volatile over the past 3 months (31% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (kr27m net loss in 2 years). Shareholders have been diluted in the past year (11% increase in shares outstanding). Market cap is less than US$100m (€32.0m market cap, or US$35.3m).
お知らせ • Dec 13Peter Schulz Joins as Interim CFO at Re:NewCell AB (publ) Effective 1 January 2024Re:NewCell AB (publ) announced Peter Schulz will join the company in the role of interim Chief Financial Officer (CFO) from 1 January 2024. He comes from a role as CFO at Pacific Basin Shipping (publ.) in Hong Kong, a position he has held for the past six years. Peter Schulz has extensive experience as CFO from both listed and private companies for the last 10 years. Prior to that Peter Schulz spent more than 15 years, and held senior positions, in investment banking in Stockholm, London and Hong Kong, among others with Royal Bank of Canada and ABN Amro. With his extensive and broad experience, he will contribute well to the management team and the company.
Breakeven Date Change • Nov 25Forecast to breakeven in 2025The 3 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 30% per year to 2024. The company is expected to make a profit of kr12.8m in 2025. Average annual earnings growth of 82% is required to achieve expected profit on schedule.
お知らせ • Jun 05Altor Equity Partners AB acquired Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ).Altor Equity Partners AB acquired Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ) on June 4, 2024.Altor Equity Partners AB completed the acquisition of Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ) on June 4, 2024.
お知らせ • Jan 10Re:NewCell AB Plans for Restructuring to Strengthen Organization Within Continuous Focus on SalesRe:NewCell AB announced that they are planning to start negotiations with the relevant trade unions regarding restructuring of the organization to improve efficiency while maintaining focus on sales. As part of the restructuring, the local authorities (Arbetsförmedlingen) will also be notified today. The planned restructuring will lead to a decrease in workforce of approximately 25%, just over 30 persons, and will also result in annual savings - reduction of personnel cost and other operating costs - of approximately 35 SEKm in total per annum when finalized.
お知らせ • Dec 23+ 1 more updateRe:NewCell AB (publ) to Report Q3, 2024 Results on Nov 06, 2024Re:NewCell AB (publ) announced that they will report Q3, 2024 results on Nov 06, 2024
New Risk • Dec 23New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: kr401m Forecast net loss in 2 years: kr27m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr578m free cash flow). Share price has been highly volatile over the past 3 months (31% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (kr27m net loss in 2 years). Shareholders have been diluted in the past year (11% increase in shares outstanding). Market cap is less than US$100m (€32.0m market cap, or US$35.3m).
お知らせ • Dec 13Peter Schulz Joins as Interim CFO at Re:NewCell AB (publ) Effective 1 January 2024Re:NewCell AB (publ) announced Peter Schulz will join the company in the role of interim Chief Financial Officer (CFO) from 1 January 2024. He comes from a role as CFO at Pacific Basin Shipping (publ.) in Hong Kong, a position he has held for the past six years. Peter Schulz has extensive experience as CFO from both listed and private companies for the last 10 years. Prior to that Peter Schulz spent more than 15 years, and held senior positions, in investment banking in Stockholm, London and Hong Kong, among others with Royal Bank of Canada and ABN Amro. With his extensive and broad experience, he will contribute well to the management team and the company.
Breakeven Date Change • Nov 25Forecast to breakeven in 2025The 3 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 30% per year to 2024. The company is expected to make a profit of kr12.8m in 2025. Average annual earnings growth of 82% is required to achieve expected profit on schedule.
Breakeven Date Change • Nov 24Forecast to breakeven in 2025The 3 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 30% per year to 2024. The company is expected to make a profit of kr12.8m in 2025. Average annual earnings growth of 82% is required to achieve expected profit on schedule.
Reported Earnings • Nov 08Third quarter 2023 earnings released: kr2.31 loss per share (vs kr2.99 loss in 3Q 2022)Third quarter 2023 results: kr2.31 loss per share (improved from kr2.99 loss in 3Q 2022). Revenue: kr86.1m (up kr83.1m from 3Q 2022). Net loss: kr94.5m (loss narrowed 6.9% from 3Q 2022). Revenue is forecast to grow 82% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Germany.
New Risk • Nov 08New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 1.4% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr786m free cash flow). Share price has been highly volatile over the past 3 months (29% average weekly change). Earnings are forecast to decline by an average of 1.4% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (kr107m net loss in 2 years). Shareholders have been diluted in the past year (13% increase in shares outstanding). Market cap is less than US$100m (€35.4m market cap, or US$37.8m).
お知らせ • Nov 07Re:NewCell AB (publ) to Report Fiscal Year 2023 Final Results on Apr 26, 2024Re:NewCell AB (publ) announced that they will report fiscal year 2023 final results on Apr 26, 2024
お知らせ • Oct 18Re:NewCell AB (publ) Announces CEO ChangesRe:NewCell AB (publ) announced that the Board has appointed Magnus Håkansson as the new acting CEO. Magnus has solid experience from leading roles in the retail and fashion sector and from leadership in a listed environment. He will start on October 16, 2023 and replaces Patrik Lundström, who has been the company's CEO since 2019. Magnus Håkansson was born in 1963, has a degree in economics from the Stockholm School of Economics and an MBA from MIT Sloan School of Management. He started his career as a management consultant at McKinsey and has since held several leading roles in global growth companies in the retail sector, as well as the pulp industry, including many years with experience from a listed environment. He most recently came from a role as CEO of MediaMarkt Sweden.
Breakeven Date Change • Oct 16Forecast breakeven date pushed back to 2025The 3 analysts covering Re:NewCell previously expected the company to break even in 2024. New consensus forecast suggests losses will reduce by 52% per year to 2024. The company is expected to make a profit of kr378.3m in 2025. Average annual earnings growth of 104% is required to achieve expected profit on schedule.
New Risk • Oct 13New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €49.0m (US$51.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr786m free cash flow). Share price has been highly volatile over the past 3 months (24% average weekly change). Minor Risks Shareholders have been diluted in the past year (22% increase in shares outstanding). Significant insider selling over the past 3 months (€1.4m sold). Market cap is less than US$100m (€49.0m market cap, or US$51.4m).
お知らせ • Oct 13Re:Newcell AB (Publ) Provides Earnings Guidance for the Third Quarter of 2023Re:NewCell AB (publ) provided earnings guidance for the third quarter of 2023. For the quarter, the company expected to report Net loss of approximately SEK 105 million.
Recent Insider Transactions • Oct 10CEO & MD recently sold €299k worth of stockOn the 6th of October, Patrik Lundstrom sold around 109k shares on-market at roughly €2.74 per share. This transaction amounted to 12% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth €1.4m. Patrik has been a net seller over the last 12 months, reducing personal holdings by €1.7m.
Reported Earnings • Aug 30Second quarter 2023 earnings released: kr2.82 loss per share (vs kr2.09 loss in 2Q 2022)Second quarter 2023 results: kr2.82 loss per share (further deteriorated from kr2.09 loss in 2Q 2022). Revenue: kr86.0m (up kr83.5m from 2Q 2022). Net loss: kr105.4m (loss widened 54% from 2Q 2022). Revenue is forecast to grow 78% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany.
お知らせ • Aug 30+ 2 more updatesRe:NewCell AB (publ) to Report Q4, 2023 Results on Feb 13, 2024Re:NewCell AB (publ) announced that they will report Q4, 2023 results on Feb 13, 2024
Breakeven Date Change • Aug 24Forecast breakeven date pushed back to 2025The 2 analysts covering Re:NewCell previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of kr233.9m in 2025. Average annual earnings growth of 73% is required to achieve expected profit on schedule.
Recent Insider Transactions • Aug 01CEO & MD recently sold €1.4m worth of stockOn the 27th of July, Patrik Lundstrom sold around 224k shares on-market at roughly €6.20 per share. This transaction amounted to 33% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Patrik's only on-market trade for the last 12 months.
お知らせ • Jul 17Re:NewCell AB (publ) Announces Toby Lawton to Leave His Position as CFORe:NewCell AB (publ) Toby Lawton, CFO at Renewcell AB (publ), has announced that he will leave his position for a similar position in another company. Toby will continue to work as CFO until a successor has been appointed or at the latest until the end of the year.
お知らせ • Jul 01Re:Newcell AB (Publ) Provides Production from Renewcell 1 Guidance in June 2023Re:NewCell AB (publ) provided production from Renewcell 1 guidance in June 2023. Production from Renewcell 1 is expected to reach 2,200-2,400 metric tons in June 2023, of which 2,100-2,300 metric tons are expected to be of prime quality and 2,200-2,400 metric tons are expected to be delivered to customers. The production in the month has been impacted by maintenance stops to upgrade and install new equipment in the shredding area.
Reported Earnings • Apr 30Full year 2022 earnings released: kr8.99 loss per share (vs kr4.33 loss in FY 2021)Full year 2022 results: kr8.99 loss per share (further deteriorated from kr4.33 loss in FY 2021). Net loss: kr299.9m (loss widened 125% from FY 2021). Revenue is forecast to grow 71% p.a. on average during the next 3 years, compared to a 1.7% growth forecast for the Chemicals industry in Germany.
お知らせ • Feb 16+ 1 more updateRe:NewCell AB (publ) to Report Q3, 2023 Results on Nov 07, 2023Re:NewCell AB (publ) announced that they will report Q3, 2023 results on Nov 07, 2023
Reported Earnings • Feb 16Full year 2022 earnings released: kr8.99 loss per share (vs kr4.33 loss in FY 2021)Full year 2022 results: kr8.99 loss per share (further deteriorated from kr4.33 loss in FY 2021). Net loss: kr299.9m (loss widened 125% from FY 2021). Revenue is forecast to grow 69% p.a. on average during the next 3 years, compared to a 1.5% growth forecast for the Chemicals industry in Germany.
Breakeven Date Change • Feb 08Forecast to breakeven in 2024The 2 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of kr51.6m in 2024. Average annual earnings growth of 66% is required to achieve expected profit on schedule.
Breakeven Date Change • Nov 29Forecast breakeven date pushed back to 2024The 2 analysts covering Re:NewCell previously expected the company to break even in 2023. New consensus forecast suggests losses will reduce by 22% per year to 2023. The company is expected to make a profit of kr118.9m in 2024. Average annual earnings growth of 72% is required to achieve expected profit on schedule.
Board Change • Nov 16High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Independent Director Om Bhatia is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Nov 04Re:Newcell AB (Publ) Appoints Tricia Carey as Chief Commercial OfficerRe:NewCell AB (publ) strengthens its commercial team with the addition of Tricia Carey as Chief Commercial Officer. Mrs. Carey is a seasoned fashion industry executive with more than 25 years of experience promoting more circular and more sustainable materials within fashion. She has also been a catalyst for the industry-wide conversation around the shift to more climate-friendly and resource-efficient materials as a board member at Textile Exchange and Accelerating Circularity. Prior to joining Renewcell, Mrs. Carey held the position of Director of Global Business Development at the leading Austrian fiber producer Lenzing. About Tricia Carey: Throughout her career, Tricia believes in ‘progress over perfection'. As an advocate for innovation and circularity in the textile and apparel industry, she recently joined Renewcell to accelerate the commercial development of Circulose®, making fashion circular. With a vast global network, as well as experience in brand building, and business development, she will be an important partner to close the loop and optimize the benefits of Circulose®. For more than twenty years, Tricia held various commercial management positions at Lenzing Fibers to establish the TENCEL™ brand, build mill partners and set retailer specifications. Her roles comprised marketing, Americas business development, and global denim segment expansion including the creation of the Carved in Blue platform and numerous collaborative collections with mills and brands. Tricia holds a bachelor's degree in Fashion Merchandising from The Fashion Institute of Technology, as well as certificates in Digital Marketing and Strategy from Cornell University and MIT.
Reported Earnings • Oct 29Third quarter 2022 earnings released: kr2.99 loss per share (vs kr0.80 loss in 3Q 2021)Third quarter 2022 results: kr2.99 loss per share (further deteriorated from kr0.80 loss in 3Q 2021). Net loss: kr101.5m (loss widened 314% from 3Q 2021). Revenue is forecast to grow 82% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat.
Breakeven Date Change • Oct 29Forecast breakeven date pushed back to 2024The 2 analysts covering Re:NewCell previously expected the company to break even in 2023. New consensus forecast suggests losses will reduce by 65% per year to 2023. The company is expected to make a profit of kr122.1m in 2024. Average annual earnings growth of 75% is required to achieve expected profit on schedule.
お知らせ • Oct 28+ 1 more updateRe:NewCell AB (publ) to Report Q2, 2023 Results on Aug 18, 2023Re:NewCell AB (publ) announced that they will report Q2, 2023 results on Aug 18, 2023
Reported Earnings • Aug 27Second quarter 2022 earnings released: kr2.09 loss per share (vs kr0.76 loss in 2Q 2021)Second quarter 2022 results: kr2.09 loss per share (down from kr0.76 loss in 2Q 2021). Net loss: kr68.4m (loss widened 192% from 2Q 2021). Over the next year, revenue is forecast to grow 3,859%, compared to a 2.4% growth forecast for the Chemicals industry in Germany.
お知らせ • Jul 05Re:NewCell AB Appoints Toby Lawton as New Chief Financial Officer, Effective October 1, 2022Re:NewCell AB (publ) announced that Toby Lawton will join the company in the role of Chief Financial Officer. He comes from a role as CFO at SCA, a position he has held for the past five years. Toby brings extensive experience from leadership positions over a two decade career with the publicly listed companies Svenska Cellulosa AB (SCA) in Sweden and Vinda International in Hong Kong. His expertise in financing large scale international projects and operational management within pulp and paper and consumer products industries will strengthen Renewcell’s scaling efforts. Toby Lawton will assume his new position at Renewcell on October 1, 2022. Hugo Petit, Renewcell’s current CFO, will remain as CFO until October 1, 2022.
Board Change • Jun 02High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Independent Director Om Bhatia is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • May 18Re:Newcell AB (Publ) Announces Executive ChangesRe:NewCell AB (publ) announced that at its Annual General Meeting held on 17 May 2022 elected Michael Berg as members of the Board of Directors for the period until the end of the next Annual General Meeting. It was noted that Mia Hemmingson has declined re-election as Chairman of the Board. Michael Berg was elected Chairman of the Board.
Reported Earnings • May 05First quarter 2022 earnings released: kr1.75 loss per share (vs kr0.63 loss in 1Q 2021)First quarter 2022 results: kr1.75 loss per share (down from kr0.63 loss in 1Q 2021). Net loss: kr54.0m (loss widened 181% from 1Q 2021). Over the next year, revenue is forecast to grow 4,106%, compared to a 8.5% growth forecast for the industry in Germany.
お知らせ • May 05Re:NewCell AB (publ) to Report Q1, 2023 Results on May 03, 2023Re:NewCell AB (publ) announced that they will report Q1, 2023 results on May 03, 2023
Board Change • Apr 27High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Om Bhatia is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Breakeven Date Change • Mar 09Forecast breakeven date moved forward to 2023The 2 analysts covering Re:NewCell previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of kr37.9m in 2023. Average annual earnings growth of 59% is required to achieve expected profit on schedule.
Breakeven Date Change • Feb 19Forecast breakeven date moved forward to 2023The 2 analysts covering Re:NewCell previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of kr37.9m in 2023. Average annual earnings growth of 59% is required to achieve expected profit on schedule.
Reported Earnings • Feb 17Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: kr4.33 loss per share (down from kr3.34 loss in FY 2020). Net loss: kr133.4m (loss widened 94% from FY 2020). Revenue exceeded analyst estimates by 10%. Over the next year, revenue is forecast to grow 1,979%, compared to a 6.5% growth forecast for the industry in Germany.
お知らせ • Feb 17Re:NewCell AB (publ) to Report Q4, 2022 Results on Feb 15, 2023Re:NewCell AB (publ) announced that they will report Q4, 2022 results on Feb 15, 2023
お知らせ • Feb 16Re:NewCell AB (publ) Provides Production Guidance for the Year 2022Re:NewCell AB (publ) provided production guidance for the year 2022. The company expects production of 60,000 metric tons.
お知らせ • Feb 07+ 2 more updatesRe:NewCell AB (publ), Annual General Meeting, May 17, 2022Re:NewCell AB (publ), Annual General Meeting, May 17, 2022.
Breakeven Date Change • Jan 28Forecast to breakeven in 2024The 2 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of kr5.77m in 2024. Average annual earnings growth of 59% is required to achieve expected profit on schedule.
Breakeven Date Change • Jan 07Forecast to breakeven in 2024The 2 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of kr5.77m in 2024. Average annual earnings growth of 59% is required to achieve expected profit on schedule.
Breakeven Date Change • Jan 01Forecast to breakeven in 2024The 2 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of kr5.77m in 2024. Average annual earnings growth of 59% is required to achieve expected profit on schedule.
Reported Earnings • Nov 07Third quarter 2021 earnings released: kr0.80 loss per share (vs kr0.81 loss in 3Q 2020)Third quarter 2021 results: Net loss: kr24.5m (loss widened 55% from 3Q 2020).
Recent Insider Transactions • Jun 25Plant Manager Ortviken recently bought €11k worth of stockOn the 21st of June, Henrik Dahlbom bought around 700 shares on-market at roughly €15.19 per share. In the last 3 months, there was an even bigger purchase from another insider worth €51k. Insiders have collectively bought €148k more in shares than they have sold in the last 12 months.
Recent Insider Transactions • Jun 13Chief Executive Officer recently bought €51k worth of stockOn the 11th of June, Patrik Lundstrom bought around 3k shares on-market at roughly €18.20 per share. This was the largest purchase by an insider in the last 3 months. This was Patrik's only on-market trade for the last 12 months.
Executive Departure • May 22Director has left the companyOn the 19th of May, Erik Karlsson's tenure in the role of Director ended. We don't have any record of a personal shareholding under Erik's name. A total of 3 executives have left over the last 12 months.
Executive Departure • May 22Director has left the companyOn the 19th of May, Henrik Norlin's tenure in the role of Director ended. We don't have any record of a personal shareholding under Henrik's name. A total of 3 executives have left over the last 12 months.
Reported Earnings • May 05First quarter 2021 earnings releasedFirst quarter 2021 results: Net loss: kr19.3m (loss widened 58% from 1Q 2020).
お知らせ • Mar 05Renewcell Awarded Afry an Engineering Assignment for Their Recycled Textile Materials Production Expansion at Sca's Ortviken Paper Mill in Sundsvall, SwedenRenewcell has awarded AFRY an engineering assignment for their recycled textile materials production expansion at SCA's Ortviken paper mill in Sundsvall, Sweden. The assignment includes project and construction management services, process, mechanical and piping engineering, electrical, automation and instrumentation engineering, fire and HVAC design, as well as civil design. The project is a continuation of AFRY's previous feasibility studies. The trend in textiles and design requires sustainable fashion. Customers require fashion companies to reduce their environmental impact through new technologies and innovations for the circular economy. One important element is recycling of textile fibers that is a path towards a more sustainable fashion.
